Figure 6
Forest plots of the included studies comparing symptomatic deep vein thrombosis (a) and symptomatic pulmonary embolism (b) in patients who received rivaroxaban and those who received enoxaparin.
Figure 6 | Scientific Reports
Forest plots of the included studies comparing symptomatic deep vein thrombosis (a) and symptomatic pulmonary embolism (b) in patients who received rivaroxaban and those who received enoxaparin.
